Testosterone and Mortality: An Expert Interview With Dr. Adrian S. Dobs CME

Author Information and Disclosures

Release Date: January 30, 2008; Valid for credit through January 30, 2009

Credits Available
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Auxilium
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss recent findings on the associations between endogenous testosterone levels and cardiovascular disease, including mortality due to cardiovascular disease
  2. Review associations between testosterone and other risk factors in men's health, especially prostate cancer
  3. Discuss the possible role of testosterone replacement therapy in reducing cardiovascular disease, cardiovascular death, and all-cause death
Authors and Disclosures

Adrian S. Dobs, MD, MHS
Disclosure: Adrian S. Dobs, MD, MHS, has disclosed that she has received grants for clinical research from Ardana, ProStrakan, and Indevus.


Emma Hitt, PhD
Disclosure: Emma Hitt, PhD, has disclosed no relevant financial relationships.


David McNeel
Disclosure: David McNeel has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.